AN2 Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Mar 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 17, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We operate primarily as a remote‑first organization. We do not own any real property. We use coworking or flexible office space in Menlo Park, California that serves as our registered address and for meetings or collaboration on an as-needed basis. We believe that our current facilities arrangement will be adequate for our near-term needs. If required, we believe that suitable space would be available in the future on commercially reasonable terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.